Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Details)

v3.21.2
Shareholders' Deficit (Details) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 03, 2021
May 04, 2021
Apr. 07, 2021
Apr. 01, 2021
Mar. 08, 2021
Feb. 01, 2021
Jan. 18, 2021
Jan. 07, 2021
Jan. 06, 2021
May 08, 2020
Apr. 17, 2020
Jan. 13, 2020
Dec. 12, 2019
Apr. 28, 2021
Mar. 19, 2021
Feb. 24, 2021
Aug. 20, 2020
Feb. 20, 2020
Feb. 18, 2020
Apr. 28, 2021
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Jul. 22, 2021
Mar. 31, 2021
Apr. 28, 2020
Shareholders' Deficit (Details) [Line Items]                                                        
Accrued dividend payable                                             $ 6,885          
Common shares per share (in Dollars per share)                       $ 0.04                                
Gross proceeds                   $ 161,000                                    
Investor purchase (in Shares)                   7,000,000                                    
Common shares per share (in Dollars per share)       $ 20,000           $ 0.023                     $ 0.001   $ 0.001   $ 0.001 $ 0.025   $ 0.04
Stock-based professional fees $ 6,000                                       $ 292,193 $ 150,539 $ 516,946 $ 287,080        
Prepaid expenses                                         $ 38,250   $ 38,250          
Common stock issued (in Shares)                                         241,050,965   241,050,965   228,346,974   500,000  
Common stock per share (in Dollars per share)       $ 0.04                                                
Accretion amount                                               5,000        
Consulting fees                                               15,000        
Prepaid expenses                                             $ 24,050          
Vesting period                                             9 months          
Common stock, description     On April 7, 2021, the Company issued 2,500,000 shares of its common stock for investor relations services to be rendered. These shares were valued at $135,000, or $0.054 per common share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares, the Company recorded stock-based professional fees of $135,000.                                                   
Company issued (in Shares) 200,000                                                      
Common share value $ 6,000                                                      
Closing price per share (in Dollars per share) $ 0.03                                                      
Stock-based professional fees                                             $ 43,250          
Accretion of stock-based professional fees                                             $ 5,000          
Stock-based compensation, description                                             Pursuant to this employment agreement, the Company agreed to grant a restricted stock award of 200,000 common shares of the Company which will vest on May 1, 2021. If the employee’s employment is terminated without cause or for good reason (both as defined in the employment agreement), or a change of control event (as defined in the employment agreement) occurs, these shares will immediately vest. For any other termination of employment, unvested restricted stock shall immediately terminate. These shares were valued on the date of grant at $8,000, or $0.04 per common share, based on contemporaneous common share sales. In connection with these shares, the Company shall record stock-based compensation over the vesting period.          
Aggregate common shares (in Shares)                                                       6,750,000
Stock based compensation value                                                       $ 270,000
Vested date                                       May 01, 2021                
Equity vested rate                                                       100.00%
Issued shares of common stock (in Shares)               1,008,000                                        
Stock-based compensation expense on granted non-vested                                         $ 159,746 287,587 $ 159,746 287,587        
Unrecognized compensation expense                                             126,504          
Shares of common stock upon conversion (in Shares)                       151,456                                
Accounts payable                       $ 6,058                                
Common shares converted (in Shares)                     203,125                                  
Accrued interest                     $ 16,250                                  
Cashless exercise of warrants (in Shares)               1,050,000                                        
Compensation expense related to stock options                                             0 $ 382,615        
Total unrecognized compensation expense related to unvested stock options                                         0   0          
Warrant purchase, description               the Company issued 1,008,000 shares of its common stock in connection with the cashless exercise of 1,050,000 warrants. The exercise price was based on contractual terms of the related warrant.                                        
Business Development [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Common shares per share (in Dollars per share)         $ 0.066 $ 0.078     $ 0.10                                      
Shares of grant restricted stock award of common shares (in Shares)                 100,000                                      
Value of grant restricted stock award of common shares         $ 49,500 $ 54,600     $ 10,000                                      
Stock-based professional fees           $ 6     $ 10,000                           36,667          
Prepaid expenses                                         12,833   12,833          
Aggregate shares of common stock (in Shares)         750,000 700,000                                            
Workers' Compensation Insurance [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Prepaid expenses                                         30,550   30,550          
Investor [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Purchase of shares (in Shares)                                     7,000,000                  
Cash proceeds from investor                                     $ 280,000                  
Common shares per share (in Dollars per share)                                     $ 0.04                  
Shares Issued for Accounts Payable [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Common shares per share (in Dollars per share)   $ 0.031                                                    
Company issued (in Shares)   3,801,224                                                    
Accounts payable   $ 117,838                                                    
Issued for Debt Conversion [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Debt conversion, description                                               the Company issued 13,275,000 shares of its common stock upon the conversion of convertible notes with bifurcated embedded conversion option derivatives including principal of $74,250, accrued interest of $28,085, and fees of $1,750. The conversion price was based on contractual terms of the related debt. The Company accounted for the partial conversion of these convertible notes pursuant to the guidance of ASC 470-20, Debt with Conversion and Other Options. Under ASC 470-20, the Company recognized an aggregate loss on debt extinguishment upon conversion in the amount of $123,455 which is associated with the different between the fair market value of the shares issued upon conversion and the conversion price and is equal to the fair value of the additional shares of common stock transferred upon conversion.        
Consulting Agreement [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Common shares per share (in Dollars per share)                                   $ 0.04                    
Shares of grant restricted stock award of common shares (in Shares)                                   1,250,000                    
Value of grant restricted stock award of common shares                                   $ 50,000                    
Stock-based professional fees                                               $ 33,333        
Prepaid expenses                                           $ 16,667   $ 16,667        
General Release Agreement [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Accrued compensation                             $ 40,625                          
Common shares per share (in Dollars per share)                             $ 0.059                          
Issued shares of common stock (in Shares)                             944,767                          
Value of issued shares of common stock                             $ 55,741                          
Stock-based compensation                             $ 15,116                          
Sales Manager [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Common shares per share (in Dollars per share)           $ 0.078                                            
Vested date           May 01, 2022                                            
Issued shares of common stock (in Shares)           200,000                                            
Value of issued shares of common stock           $ 15,600                                            
Officer [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Common shares per share (in Dollars per share)         $ 0.066                                              
Shares of grant restricted stock award of common shares (in Shares)         2,500,000                                              
Value of grant restricted stock award of common shares         $ 165,000                                              
Vested date         May 01, 2022                                              
Series B Preferred Stock [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Designations established share (in Shares)                         100,000                              
Preferred Stock par value (in Shares)                         0.10                              
Stated value                         $ 1,000                              
Preferred Stock dividend Rate                         2.00%                              
Stock option, description                         The Series B is convertible into common stock at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion Price for a period of twenty consecutive trading days, at the option of the Company. Conversion Price means a price per share of the common stock equal to 100% of the lowest daily volume weighted average price of the common stock during the two years preceding or subsequent two years following the Issuance Date, subject to adjustment as otherwise provided in the Certificate of Designations (the “Conversion Price”).                               
Accrued compensation             $ 295,000                                          
Accrued compensation shares (in Shares)             295                                          
Stock based compensation             $ 3,778,810                                          
Accrued dividend payable                                             9,362   $ 2,476      
Preferred stock balance                                         731,332   731,332   429,446      
Liquidation value                                         721,970   721,970   426,970      
Series C Preferred Stock [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Designations established share (in Shares)                                 100,000                      
Preferred Stock par value (in Shares)                                 0.10                      
Stated value                                 $ 100               1,330,000      
Preferred Stock dividend Rate                                 2.00%                      
Accrued dividend payable                                             20,962   6,031      
Preferred stock balance                                         1,600,962   1,600,962   $ 1,336,031      
Liquidation value                                         $ 1,580,000   1,580,000          
Percentage of stated value                                 150.00%                      
Outstanding shares percent                           4.99%                            
Series C Convertible Preferred Stock [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Accrued dividend payable                               $ 2,845,238             $ 14,931          
Purchase of shares (in Shares)                               2,500                        
Series A Preferred Stock [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Preferred shares, description                                               the Company issued 9,982,616 shares its common stock upon the conversion of 159,600 shares of Series A preferred with a stated redemption value of $159,600 and related accrued dividends payable of $3,192. The conversion price was based on contractual terms of the related Series A preferred shares. Upon conversion, the Company reclassified put premium of $37,438 to paid-in capital.        
Maximum [Member] | Series C Convertible Preferred Stock [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Stated value                               $ 250,000                        
Minimum [Member] | Series C Convertible Preferred Stock [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Stated value                               $ 100.00                        
2018 Long-Term Incentive Plan [Member]                                                        
Shareholders' Deficit (Details) [Line Items]                                                        
Stock option, description                                             The aggregate number of shares of common stock and number of shares of the Company’s common stock that may be subject to incentive stock options granted under the 2018 Plan is 50,000,000 shares, of which 11,445,698 shares have been issued or granted under incentive stock options and 28,451,070 shares of restricted stock have been issued as of June 30, 2021.          
Aggregate shares of common stock (in Shares)                                             25,000,000          
Description of options to acquire common stock                                             The exercise price of options granted under our 2018 Plan must at least be equal to the fair market value of the Company’s common stock on the date of grant and the term of an option may not exceed ten years, except that with respect to an incentive stock option granted to any employee who owns more than 10% of the voting power of all classes of the Company’s outstanding stock as of the grant date the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date.